NAT-POMALIDOMIDE
Identification of Nat-Pomalidomide
| No description |
Google image searchProduct monograph
Active ingredient
pomalidomide, 3 MG
DIN: 02506416
Dosage form(s): CAPSULE
Route(s) of administration: ORAL
Schedule: Prescription
Company: NATCO PHARMA (CANADA) INC
Date: 28-FEB-2023
ATC:
- L04 — IMMUNOSUPPRESSANTS (ATC, ATC/DDD, )
- L04A — IMMUNOSUPPRESSANTS (ATC, ATC/DDD)
- L04AX — Other immunosuppressants (ATC, ATC/DDD)
- L04AX06 — POMALIDOMIDE (ATC/DDD)
Reference brand drug: Pomalyst
